News About: Pharm. Industry
Ilsung, Dalim withdraw suit
Four drug companies filed a suit against the Ministry of Health and Welfare on March 7 and March 9, claiming the government’s drug price cuts will deal a big blow to their revenues.
However, Ilsung Pharmaceutical a...
KPMA to reinforce advisory body’s function
The Korea Pharmaceutical Manufacturers Association unveiled its plan to strengthen the function of its advisory committee consisting of 13 high-profile figures from leading drug firms.
In a board of directors’ meet...
Kim to head pharmaceutical group
Kim Dae-joong, CEO of Daiichi-Sankyo Korea, was elected president of the Korea Japanese Pharmaceutical Association (KJPA) as of March 13, the association said.
Kim will replace incumbent Hukuyama Mashashi, CEO of D...
Boryung’s new antihypertensive drug published in peer journal
Boryung Pharmaceutical Co. says that the efficacy and safety of its Kanarb (fimasartan), a homegrown antihypertensive drug, are fully demonstrated in the global scientific arena.
The results of Phase III study of K...
Hanmi forges strategic tie-up with GSK
Hanmi Pharmaceutical Co. announced yesterday it signed an agreement with GlaxoSmithKline (GSK), a U.K.-based pharmaceutical and health care company, to co-develop and commercialize combination products at the British ...
Chong Kun Dang teams up with B.Brown Korea
Chong Kun Dang Pharmaceutical, Korea’s leading drug manufacturer, said yesterday that it has established a marketing and distribution partnership with B.Brown Korea.
Under the deal, Chong Kun Dang will be in charge...
Four companies seeking to secure injunction against drug price cuts
Domestic four drug makers and the government are at odds over the new regulation slashing drug prices by an average of 14 percent from April 1.
The four drug companies, such as Ilsung Pharmaceuticals, Elyson Pharm...
Government-imposed price cuts haunt drugmakers
Domestic pharmaceutical companies are now bracing for the effects of government-imposed price cuts that will make domestic drug makers suffer by eroding profitability.
Last month, the Ministry of Health and Welfare...
New executives to head KPMA
The Korea Pharmaceutical Manufacturers Association said Monday it will announce a list of new executives, which has been delayed since the nomination of its new president Yoon Suk-geun on Feb. 23.
The association w...
New cancer pill gives hope and strategy
Pfizer Korea’s just-launched drug Xalkori (crizotinib), the first new medicine for deadly lung cancer, proves the value of precisely targeting rare diseases linked to gene variants, cancer specialists said.
Pfizer ...
